We provide you with 20 years of free, institutional-grade data for NOVN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NOVN. Explore the full financial landscape of NOVN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Novan, Inc(NASDAQ:NOVN) 
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical ant...
Website: http://www.novan.com
Founded: 2006
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about NOVN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.